Intuitive Surgical Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 02/04/2023
Intuitive Surgical Inc Stock Forecast and Price Target
Year-long price target forecasts from thridteen prominent analysts have recently been released for Intuitive Surgical Inc, with an average price target of $282.00. This potential gain of 10.73 percent from the previous closing price in February, 2023 is calculated on a high forecast of $325.00 and a low estimate of $204.00. If you're looking for information on Intuitive Surgical Inc stock, consider checking out the forecasts for comparable firms such as NYSE:RMD.
10.73% Upside
Intuitive Surgical Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Intuitive Surgical Inc's Price has grown, increasing from $210.93 to $246.16 – a growth of 16.71%. The next year looks promising for Intuitive Surgical Inc, with analysts predicting Fair Value of $292.32 – an increase of 18.75%. Over the next eight years, experts anticipate that Intuitive Surgical Inc's Fair Value will grow at a rate of 212.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$111.79 | $120.97 | 11.82% |
| BSX Stock Forecast | Boston Scientific | Outperform |
15
|
$48.50 | $50.77 | 3.09% |
| DXCM Stock Forecast | DexCom | Outperform |
16
|
$108.43 | $121.12 | 15.74% |
| RMD Stock Forecast | ResMed | Outperform |
17
|
$224.60 | $251.67 | 12.42% |
| PODD Stock Forecast | Insulet | Outperform |
15
|
$295.19 | $302.13 | 8.40% |
Intuitive Surgical Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Intuitive Surgical Inc's Revenue has grown, increasing from $4.48B to $6.22B – a growth of 38.93%. The next year looks promising for Intuitive Surgical Inc, with analysts predicting Revenue of $7.20B – an increase of 15.71%. Over the next eight years, experts anticipate that Intuitive Surgical Inc's Revenue will grow at a rate of 158.86%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| NYSE:VAR Stock Forecast | Varian Medical Systems | - |
16
|
$0.00 | $0.00 | 0.00% |
| MASI Stock Forecast | Masimo | Outperform |
14
|
$169.45 | $166.14 | 0.32% |
| SWAV Stock Forecast | ShockWave Medical | Outperform |
4
|
$187.32 | $0.00 | -3.91% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| LVGO Stock Forecast | Livongo Health | - |
0
|
$0.00 | $0.00 | 0.00% |
| INSP Stock Forecast | Inspire Medical Systems | Outperform |
6
|
$251.35 | $0.00 | 19.36% |
| CMD Stock Forecast | Cantel Medical | - |
17
|
$0.08 | $85.00 | 174637.50% |
Intuitive Surgical Inc Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Intuitive Surgical Inc's Free Cash Flow has grown by 194755114.61%, rising from $1.17B to $2283.70T. According to 5 major analysts, Intuitive Surgical Inc's Free Cash Flow will fall by 100.00% in the next year, reaching $2.07B. Professionals believe that By 2030, Intuitive Surgical Inc's Free Cash Flow will fall to $5.10B– a 100.00% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| AXNX Stock Forecast | Axonics | Buy |
7
|
$62.69 | $0.00 | 14.85% |
| IRTC Stock Forecast | iRhythm Technologies | Hold |
11
|
$109.29 | $0.00 | 40.91% |
| CNMD Stock Forecast | CONMED | Outperform |
16
|
$102.61 | $145.00 | 16.95% |
Intuitive Surgical Inc Net Income Forecast for 2023 - 2025 - 2030
Intuitive Surgical Inc's Net Income has decreased In the last three years, from $1.38B to $1.34B – a 2.53% drop. Next year, analysts are expecting Net Income to reach $2.15B – an increase of 59.55%. Over the next eight years, the forecast is for Net Income to grow by 248.41%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TNDM Stock Forecast | Tandem Diabetes Care | Outperform |
9
|
$45.04 | $127.93 | 104.26% |
| ITGR Stock Forecast | Integer Holdings | Buy |
16
|
$73.50 | $111.33 | 48.30% |
| GNMK Stock Forecast | GenMark Diagnostics | - |
2
|
$0.00 | $24.05 | 0.00% |
Intuitive Surgical Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Intuitive Surgical Inc's EBITDA has grown by 0.17%, rising from $1.57B to $1.58B. For next year, analysts predict EBITDA of $3.02B, which would mean an increase of 91.44%. Over the next eight years, experts predict that Intuitive Surgical Inc's EBITDA will grow at a rate of 307.01%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| NVRO Stock Forecast | Nevro | Hold |
6
|
$39.79 | $69.50 | 62.10% |
| SILK Stock Forecast | Silk Road Medical, Inc | Outperform |
7
|
$54.81 | $0.00 | -5.13% |
| TMDX Stock Forecast | TransMedics Group | Outperform |
8
|
$69.36 | $0.00 | -59.63% |
Intuitive Surgical Inc EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Intuitive Surgical Inc's EBIT has grown, rising from $1.37B to $1.82B – a growth of 32.48%. In the next year, analysts believe that EBIT will reach $2.71B – an increase of 48.67%. For the next eight years, the forecast is for EBIT to grow by 390.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| NTUS Stock Forecast | Natus Medical | - |
14
|
$32.96 | $36.00 | 70.27% |
| CUTR Stock Forecast | Cutera | Buy |
6
|
$36.23 | $42.20 | 115.29% |
| SENS Stock Forecast | Senseonics Holdings | Hold |
6
|
$1.20 | $0.00 | 108.33% |
Intuitive Surgical Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Intuitive Surgical Inc's EPS has grown, increasing from $4.25 to $4.96 – a growth of 16.71%. The next year looks promising for Intuitive Surgical Inc, with analysts predicting EPS of $5.89 – an increase of 18.75%. Over the next eight years, experts anticipate that Intuitive Surgical Inc's EPS will grow at a rate of 212.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| INGN Stock Forecast | Inogen | Outperform |
8
|
$26.00 | $44.00 | 23.08% |
| QTRX Stock Forecast | Quanterix | Buy |
11
|
$14.91 | $0.00 | 144.80% |
| VRAY Stock Forecast | ViewRay | Outperform |
7
|
$4.69 | $0.00 | 81.24% |